Please enable JavaScript to continue using this application.

Compare $AKBA vs $CAMP | Chartloom

Compare

$AKBA vs $CAMP

Akebia Therapeutics Inc · CAMP4 Therapeutics Corp

AKBA

Akebia Therapeutics Inc

CAMP

CAMP4 Therapeutics Corp

Compare $AKBA vs $CAMP

Comparing Akebia Therapeutics Inc and CAMP4 Therapeutics Corp

AKBAAkebia Therapeutics Inc

CAMPCAMP4 Therapeutics Corp

AKBAAkebia Therapeutics Inc

Market cap

$215M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.35x

Rev growth (TTM)

7.5%

YTD performance

-48.3%

52W performance

-71.9%

FCF yield

13.7%

CAMPCAMP4 Therapeutics Corp

Market cap

$196M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

19.59x

Rev growth (TTM)

40.3%

YTD performance

-37.2%

52W performance

6.5%

FCF yield

-14.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AKBA

CAMP

Detailed metrics comparison

AKBA

Akebia Therapeutics Inc

CAMP

CAMP4 Therapeutics Corp

Market Cap

AKBA$215M

CAMP$196M

Enterprise Value

AKBA$252M

CAMP$109M

Price

AKBA$0.80

CAMP$3.77

P/E Ratio

AKBAN/A

CAMPN/A

P/S Ratio

AKBA0.98x

CAMP46.44x

EV/Sales

AKBA1.15x

CAMP25.94x

EV/EBITDA

AKBA49.22x

CAMP0.00x

P/B Ratio

AKBA9.58x

CAMP8.12x

P/FCF Ratio

AKBA7.30x

CAMPN/A

EV/FCF

AKBA8.54x

CAMP-3.81x

PEG Ratio

AKBAN/A

CAMPN/A

Forward P/E (NTM)

AKBAN/A

CAMPN/A

Forward P/S (NTM)

AKBA1.35x

CAMP19.59x

Revenue (TTM)

AKBA$219M

CAMP$4M

Revenue Growth (YoY)

AKBA7.5%

CAMP40.3%

Forward Rev Growth

AKBA-33.0%

CAMP-10.8%

Gross Margin (TTM)

AKBA81.5%

CAMP35.8%

Operating Margin (TTM)

AKBA0.0%

CAMP0.0%

EBITDA Margin (TTM)

AKBA-1.9%

CAMP-1199.3%

Net Margin (TTM)

AKBA-13.5%

CAMP-2543.7%

FCF Margin (TTM)

AKBA13.4%

CAMP-681.2%

Net Income (TTM)

AKBA$-30M

CAMP$-107M

FCF (TTM)

AKBA$29M

CAMP$-29M

EPS (TTM)

AKBA-$0.11

CAMP-$1.85

ROE (TTM)

AKBA-9374.0%

CAMP-19474.0%

ROA (TTM)

AKBA-817.0%

CAMP-10642.0%

ROIC (TTM)

AKBA-1321.0%

CAMP-19457.0%

Cash

AKBA$156M

CAMP$86M

Debt

AKBA$192M

CAMP$0

Net Cash/Debt

AKBA$-37M

CAMP$86M

Current Ratio (TTM)

AKBA1.43x

CAMP4.70x

Quick Ratio (TTM)

AKBA1.31x

CAMP4.69x

Debt/Equity (TTM)

AKBA7.69x

CAMP0.00x

Debt/Assets (TTM)

AKBA0.0%

CAMP0.0%

Interest Coverage (TTM)

AKBAN/A

CAMPN/A

Net Debt/EBITDA (TTM)

AKBA0.00x

CAMP0.00x

Beta

AKBA0.20

CAMP-24.51

52W Performance

AKBA-71.9%

CAMP6.5%

YTD Performance

AKBA-48.3%

CAMP-37.2%

% from 52W High

AKBA-75.0%

CAMP-51.4%

% from 52W Low

AKBA0.0%

CAMP31.8%

Asset Turnover (TTM)

AKBA0.60x

CAMP0.79x

FCF Yield (TTM)

AKBA13.7%

CAMP-14.7%

Earnings Yield (TTM)

AKBA-13.8%

CAMP-54.8%

Dividend Yield (TTM)

AKBAN/A

CAMPN/A

Rule of 40

AKBA21.0

CAMP-640.9

EV/GP/RG

AKBAN/A

CAMP0.53

Ticker research

View AKBA research View CAMP research

Metric	AKBA Akebia Therapeutics Inc	CAMP CAMP4 Therapeutics Corp
Market & Valuation
Market Cap	$215M	$196M
Enterprise Value	$252M	$109M
Price	$0.80	$3.77
P/E Ratio	N/A	N/A
P/S Ratio	0.98x	46.44x
EV/Sales	1.15x	25.94x
EV/EBITDA	49.22x	0.00x
P/B Ratio	9.58x	8.12x
P/FCF Ratio	7.30x	N/A
EV/FCF	8.54x	-3.81x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.35x	19.59x
Revenue & Growth
Revenue (TTM)	$219M	$4M
Revenue Growth (YoY)	7.5%	40.3%
Forward Rev Growth	-33.0%	-10.8%
Profitability
Gross Margin (TTM)	81.5%	35.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-1199.3%
Net Margin (TTM)	-13.5%	-2543.7%
FCF Margin (TTM)	13.4%	-681.2%
Net Income (TTM)	$-30M	$-107M
FCF (TTM)	$29M	$-29M
EPS (TTM)	-$0.11	-$1.85
ROE (TTM)	-9374.0%	-19474.0%
ROA (TTM)	-817.0%	-10642.0%
ROIC (TTM)	-1321.0%	-19457.0%
Financial Health
Cash	$156M	$86M
Debt	$192M	$0
Net Cash/Debt	$-37M	$86M
Current Ratio (TTM)	1.43x	4.70x
Quick Ratio (TTM)	1.31x	4.69x
Debt/Equity (TTM)	7.69x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.20	-24.51
52W Performance	-71.9%	6.5%
YTD Performance	-48.3%	-37.2%
% from 52W High	-75.0%	-51.4%
% from 52W Low	0.0%	31.8%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.79x
FCF Yield (TTM)	13.7%	-14.7%
Earnings Yield (TTM)	-13.8%	-54.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	21.0	-640.9
EV/GP/RG	N/A	0.53
Ticker research	View AKBA research	View CAMP research

Valuation

P/S Ratio

AKBA

0.98x

CAMP

46.44x

EV/FCF

CAMP

-3.81x

AKBA

8.54x

Growth & revenue

Revenue Growth TTM

CAMP

40.3%

AKBA

7.5%

Forward Revenue Growth

CAMP

-10.8%

AKBA

-33.0%

Profitability & performance

Gross Margin

AKBA

81.5%

CAMP

35.8%

ROE

AKBA

-9374.0%

CAMP

-19474.0%

FCF Yield %

AKBA

13.7%

CAMP

-14.7%

52-Week Performance

CAMP

6.5%

AKBA

-71.9%

Detailed metrics comparison

AKBA

Akebia Therapeutics Inc

CAMP

CAMP4 Therapeutics Corp

Market Cap

AKBA$215M

CAMP$196M

Enterprise Value

AKBA$252M

CAMP$109M

Price

AKBA$0.80

CAMP$3.77

P/E Ratio

AKBAN/A

CAMPN/A

P/S Ratio

AKBA0.98x

CAMP46.44x

EV/Sales

AKBA1.15x

CAMP25.94x

EV/EBITDA

AKBA49.22x

CAMP0.00x

P/B Ratio

AKBA9.58x

CAMP8.12x

P/FCF Ratio

AKBA7.30x

CAMPN/A

EV/FCF

AKBA8.54x

CAMP-3.81x

PEG Ratio

AKBAN/A

CAMPN/A

Forward P/E (NTM)

AKBAN/A

CAMPN/A

Forward P/S (NTM)

AKBA1.35x

CAMP19.59x

Revenue (TTM)

AKBA$219M

CAMP$4M

Revenue Growth (YoY)

AKBA7.5%

CAMP40.3%

Forward Rev Growth

AKBA-33.0%

CAMP-10.8%

Gross Margin (TTM)

AKBA81.5%

CAMP35.8%

Operating Margin (TTM)

AKBA0.0%

CAMP0.0%

EBITDA Margin (TTM)

AKBA-1.9%

CAMP-1199.3%

Net Margin (TTM)

AKBA-13.5%

CAMP-2543.7%

FCF Margin (TTM)

AKBA13.4%

CAMP-681.2%

Net Income (TTM)

AKBA$-30M

CAMP$-107M

FCF (TTM)

AKBA$29M

CAMP$-29M

EPS (TTM)

AKBA-$0.11

CAMP-$1.85

ROE (TTM)

AKBA-9374.0%

CAMP-19474.0%

ROA (TTM)

AKBA-817.0%

CAMP-10642.0%

ROIC (TTM)

AKBA-1321.0%

CAMP-19457.0%

Cash

AKBA$156M

CAMP$86M

Debt

AKBA$192M

CAMP$0

Net Cash/Debt

AKBA$-37M

CAMP$86M

Current Ratio (TTM)

AKBA1.43x

CAMP4.70x

Quick Ratio (TTM)

AKBA1.31x

CAMP4.69x

Debt/Equity (TTM)

AKBA7.69x

CAMP0.00x

Debt/Assets (TTM)

AKBA0.0%

CAMP0.0%

Interest Coverage (TTM)

AKBAN/A

CAMPN/A

Net Debt/EBITDA (TTM)

AKBA0.00x

CAMP0.00x

Beta

AKBA0.20

CAMP-24.51

52W Performance

AKBA-71.9%

CAMP6.5%

YTD Performance

AKBA-48.3%

CAMP-37.2%

% from 52W High

AKBA-75.0%

CAMP-51.4%

% from 52W Low

AKBA0.0%

CAMP31.8%

Asset Turnover (TTM)

AKBA0.60x

CAMP0.79x

FCF Yield (TTM)

AKBA13.7%

CAMP-14.7%

Earnings Yield (TTM)

AKBA-13.8%

CAMP-54.8%

Dividend Yield (TTM)

AKBAN/A

CAMPN/A

Rule of 40

AKBA21.0

CAMP-640.9

EV/GP/RG

AKBAN/A

CAMP0.53

Ticker research

View AKBA research View CAMP research

Metric	AKBA Akebia Therapeutics Inc	CAMP CAMP4 Therapeutics Corp
Market & Valuation
Market Cap	$215M	$196M
Enterprise Value	$252M	$109M
Price	$0.80	$3.77
P/E Ratio	N/A	N/A
P/S Ratio	0.98x	46.44x
EV/Sales	1.15x	25.94x
EV/EBITDA	49.22x	0.00x
P/B Ratio	9.58x	8.12x
P/FCF Ratio	7.30x	N/A
EV/FCF	8.54x	-3.81x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.35x	19.59x
Revenue & Growth
Revenue (TTM)	$219M	$4M
Revenue Growth (YoY)	7.5%	40.3%
Forward Rev Growth	-33.0%	-10.8%
Profitability
Gross Margin (TTM)	81.5%	35.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-1199.3%
Net Margin (TTM)	-13.5%	-2543.7%
FCF Margin (TTM)	13.4%	-681.2%
Net Income (TTM)	$-30M	$-107M
FCF (TTM)	$29M	$-29M
EPS (TTM)	-$0.11	-$1.85
ROE (TTM)	-9374.0%	-19474.0%
ROA (TTM)	-817.0%	-10642.0%
ROIC (TTM)	-1321.0%	-19457.0%
Financial Health
Cash	$156M	$86M
Debt	$192M	$0
Net Cash/Debt	$-37M	$86M
Current Ratio (TTM)	1.43x	4.70x
Quick Ratio (TTM)	1.31x	4.69x
Debt/Equity (TTM)	7.69x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.20	-24.51
52W Performance	-71.9%	6.5%
YTD Performance	-48.3%	-37.2%
% from 52W High	-75.0%	-51.4%
% from 52W Low	0.0%	31.8%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.79x
FCF Yield (TTM)	13.7%	-14.7%
Earnings Yield (TTM)	-13.8%	-54.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	21.0	-640.9
EV/GP/RG	N/A	0.53
Ticker research	View AKBA research	View CAMP research